These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2886200)

  • 1. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R; Ober M; Masi R; Elman J; Novack GD; Sears ML; Batoosingh AL
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.
    Walters TR; Maloney S; Slater D; Liss C; Wilson H; Hartenbaum D
    Clin Ther; 1998; 20(6):1170-8. PubMed ID: 9916610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levobunolol compared with timolol for the control of elevated intraocular pressure.
    Geyer O; Lazar M; Novack GD; Lue JC; Duzman E
    Ann Ophthalmol; 1986 Oct; 18(10):289-90, 292. PubMed ID: 3535611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.
    Boozman FW; Carriker R; Foerster R; Allen RC; Novack GD; Batoosingh AL
    Arch Ophthalmol; 1988 May; 106(5):614-8. PubMed ID: 3282501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
    Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
    Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure after a two-week washout following long-term timolol or levobunolol.
    Hong YJ; Shin DH; Ahn BH; McCarty B
    J Ocul Pharmacol Ther; 1995; 11(2):107-12. PubMed ID: 8564631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-over trial comparing once daily levobunolol with once and twice daily timolol.
    Akafo SK; Thompson JR; Rosenthal AR
    Eur J Ophthalmol; 1995; 5(3):172-6. PubMed ID: 8845685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
    Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
    Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.